Dose Escalation and Dose Expansion Study of RMC-6291 Monotherapy in Subjects With Advanced KRASG12C Mutant Solid Tumors
Revolution Medicines, Inc.
Revolution Medicines, Inc.
Pfizer
Seagen Inc.
Elicio Therapeutics
Eli Lilly and Company
Pfizer
GlaxoSmithKline
Hoffmann-La Roche
GlaxoSmithKline
Novartis
GlaxoSmithKline
Pfizer
Medicine Invention Design, Inc
Tempus AI
Mirati Therapeutics Inc.
Amal Therapeutics